Skip to content

Advertisement

Focusing on the brain, cognition and behavior

Hans Asperger, National Socialism, and “race hygiene” in Nazi-era Vienna

New Content Item​​​​​​​

Drawing on a vast array of contemporary publications and previously unexplored archival documents (including Asperger’s personnel files and the clinical assessments he wrote on his patients) Herwig Czech offers a critical examination of Asperger’s life, politics, and career before and during the Nazi period in Austria.

Read the article​​​​​​​

Autism spectrum disorder: prospects for treatment using gene therapy

New Content Item

This review highlights how, despite a number of outstanding challenges, gene therapy has excellent potential to address cognitive dysfunction in ASD.

Read the review here

Articles

  1. Content type: Research

      |  

    Authors: Lambertus Klei, Stephan J Sanders, Michael T Murtha, Vanessa Hus, Jennifer K Lowe, A Jeremy Willsey, Daniel Moreno-De-Luca, Timothy W Yu, Eric Fombonne, Daniel Geschwind, Dorothy E Grice, David H Ledbetter, Catherine Lord, Shrikant M Mane, Christa Lese Martin, Donna M Martin…

Most accessed articles RSS

View all articles

Editors-in-Chief

Simon Baron-Cohen, University of Cambridge, UK
Joseph Buxbaum, Icahn School of Medicine at Mount Sinai, New York  

Aims and scope

Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.

We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.

Latest Tweets

Resource Identification Initiative

Molecular Autism is participating in the Resource Identification Initiative, a project designed to encourage authors to provide unambiguous identification of three types of key research resources – antibodies, model organisms, and software tools – used in the course of a scientific investigation.

JB

Joseph Buxbaum, co-Editor-in-Chief
Joseph Buxbaum is a molecular geneticist and neuroscientist, Director of the Seaver Autism Center for Research and Treatment, and Professor at the Icahn School of Medicine at Mount Sinai. Dr Buxbaum is the founder and co-lead investigator of the Autism Sequencing Consortium, an international collaboration to discover genes for autism. He has also been elected to the prestigious National Academy of Medicine (NAM), in recognition of his important contributions to uncovering the genetic and molecular basis of autism.

 

SBC

Simon Baron-Cohen, co-Editor-in-Chief
Simon Baron-Cohen is Professor of Developmental Psychopathology at the University of Cambridge and Fellow at Trinity College, Cambridge. He is also Director of the Autism Research Centre (ARC) in Cambridge and Director of CLASS (Cambridge Lifespan Asperger Syndrome Service), a clinic for adults with suspected AS.

Advertisement

2017 Journal Metrics

Advertisement